+Compare
INFU
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
211.41M

INFU InfuSystem Holdings Forecast, Technical & Fundamental Analysis

a manufacturer of external ambulatory infusion pumps

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for INFU with price predictions
07:00 PM EST Dec 06, 2023

INFU in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 08, 2023

INFU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 27 cases where INFU's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2023. You may want to consider a long position or call options on INFU as a result. In of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INFU just turned positive on November 17, 2023. Looking at past instances where INFU's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

INFU moved above its 50-day moving average on November 22, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for INFU crossed bullishly above the 50-day moving average on November 29, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INFU advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for INFU moved out of overbought territory on December 07, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INFU entered a downward trend on November 21, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INFU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.107) is normal, around the industry mean (25.240). P/E Ratio (222.222) is within average values for comparable stocks, (79.553). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (1.811) is also within normal values, averaging (44.190).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NASDAQ:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NASDAQ:MDT), Boston Scientific Corp (NASDAQ:BSX), Edwards Lifesciences Corp (NASDAQ:EW), IQVIA Holdings (NASDAQ:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.41B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -0%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -10%. SERA experienced the highest price growth at 160%, while IMMVF experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -51%. For the same stocks of the Industry, the average monthly volume growth was -20% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 87
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published General Information

General Information

a manufacturer of external ambulatory infusion pumps

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3851 West Hamlin Road
Phone
+1 248 291-1210
Employees
438
Web
http://www.infusystem.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRZIX13.500.12
+0.90%
T. Rowe Price Small-Cap Index Z
DHLTX21.000.15
+0.72%
Diamond Hill Select I
MEFNX11.930.05
+0.42%
MassMutual Mid Cap Growth R3
GLCSX10.350.04
+0.39%
Morgan Stanley Cntrpnt Global R6
IRVIX27.270.06
+0.22%
Voya Russell Large Cap Value Idx Port I

INFU and

Correlation & Price change

A.I.dvisor tells us that INFU and WRBY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INFU and WRBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
-1.70%
WRBY - INFU
32%
Poorly correlated
-0.99%
STAA - INFU
29%
Poorly correlated
+2.39%
CNMD - INFU
28%
Poorly correlated
+1.14%
BIO - INFU
28%
Poorly correlated
-0.18%
NVST - INFU
26%
Poorly correlated
+1.69%
More

Groups containing INFU

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
-1.70%
Medical Specialties
(undefined stocks)
29%
Poorly correlated
-0.02%
Medical Specialties
(undefined stocks)
29%
Poorly correlated
-0.02%
medical research
(undefined stocks)
29%
Poorly correlated
+0.03%
medical service
(undefined stocks)
29%
Poorly correlated
+0.05%